Giulia Ceglie 1,2*, Giulia Nocentini3*, Francesca De Gennaro 3, Vitangelo Clemente 3, Margherita Di Mauro3, Giuseppe Palumbo 1,3
1 Department of Pediatric Hematology and Oncology, Cell and Gene Therapy, IRCCS Bambino Gesù Children’s Hospital, Rome, Italy
2 PhD Program in Immunology, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, 00133 Rome, Italy
3 University Department of Pediatrics, Bambino Gesù Children’s Hospital, University of Rome Tor Vergata, Rome, Italy
*These authors contributed equally.
Correspondence : Giulia Ceglie, M.D., Department of Pediatric Hematology and Oncology, Cell and Gene Therapy, IRCCS Bambino Gesù Children’s Hospital, Piazza Sant’Onofrio 4, 00165, Rome, Italy